All News

Reports of incubators' demise were premature

Universities are funding more campus companies. Richard L. Hudson on the rules of a very risky game.

After the initial hype, the long haul through clinical development and the inevitable pitfalls, gene therapy is on the verge of becoming a commercial reality in Europe - ahead of the US.

If you want to lead innovation in R&D, don’t neglect the crucial human factor, says Georges Haour from the IMD in Lausanne, Switzerland.

Physicists in Bangalore have developed new uses for carbon nanotubes – as flow sensors. Now they are looking for more licensees to develop their work.

A spin-out from the University of Southampton, UK, has a new “scintillation detector” that it says can help stop radiological threats at airports and elsewhere.

A novel procedure for the preparation of β-lactams, from non-natural substrates.

New technology to repair the meniscus in the knee is under development at the University of Bristol, UK.

This device delivers large molecules directly into cells, and even into specific sites within cells, whilst avoiding the cellular damage associated with other drug delivery methods.

Undersea automation to deal with imaging, inspection, mapping, profiling, surveillance, classification and exploration.

How to manage a virtual R&D team, valuing research – and other insights into R&D management.

A new class of antibiotics, to tackle MRSA and other multi-resistant organisms, is in development by a spin-off from the University of Surrey, UK.

Mary Lisbeth D'Amico's fortnightly funding column looks at the contenders for Europe’s premier exchange for growth stocks.

To change the physical characteristics of existing polymers for new market opportunities such as non-stick chewing gum.